Ziqing Li

Jinan, 250021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Pharmacological inhibition of Htr2b ameliorates bone destruction in glucocorticoid-induced osteonecrosis of the femoral head by suppressing Ca2+/ERK ‑ dependent osteoclast hyperactivation.

Pharmacological inhibition of Htr2b ameliorates bone destruction in glucocorticoid-induced osteonecrosis of the femoral head by suppressing Ca2+/ERK ‑ dependent osteoclast hyperactivation.

Journal: Biochemical pharmacology

Published: February 19, 2026

Skimmianine Attenuates Osteoclast Activity by Suppressing ERp57-Driven Calcium Oscillations/Calcineurin/Nfatc1 Signalling in Postmenopausal Osteoporosis.

Skimmianine Attenuates Osteoclast Activity by Suppressing ERp57-Driven Calcium Oscillations/Calcineurin/Nfatc1 Signalling in Postmenopausal Osteoporosis.

Journal: Journal of cellular and molecular medicine

Published: April 17, 2025

Recent advances in osteonecrosis of the femoral head: a focus on mesenchymal stem cells and adipocytes.

Recent advances in osteonecrosis of the femoral head: a focus on mesenchymal stem cells and adipocytes.

Journal: Journal of translational medicine

Published: October 13, 2024

Norwogonin Attenuates Inflammatory Osteolysis and Collagen-Induced Arthritis via Modulating Redox Signalling and Calcium Oscillations.

Norwogonin Attenuates Inflammatory Osteolysis and Collagen-Induced Arthritis via Modulating Redox Signalling and Calcium Oscillations.

Journal: Journal of cellular and molecular medicine

Published: August 26, 2024

Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axis.

Quercetagetin alleviates inflammatory osteoclastogenesis and collagen antibody-induced arthritis via Nrf2 signaling and Pten/AKT/Nfatc1 axis.

Journal: Arthritis research & therapy

Published: August 15, 2024

Corydaline attenuates osteolysis in rheumatoid arthritis via mitigating reactive oxygen species production and suppressing calcineurin-Nfatc1 signaling.

Corydaline attenuates osteolysis in rheumatoid arthritis via mitigating reactive oxygen species production and suppressing calcineurin-Nfatc1 signaling.

Journal: International immunopharmacology

Published: June 20, 2024

Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis of the femoral head by suppressing osteoclast activity through the reduction of cellular oxidative stress.

Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis of the femoral head by suppressing osteoclast activity through the reduction of cellular oxidative stress.

Journal: Chemico-biological interactions

Published: May 13, 2024

Suppressing ERp57 diminishes osteoclast activity and ameliorates ovariectomy-induced bone loss via the intervention in calcium oscillation and the calmodulin/calcineurin/Nfatc1 pathway.

Suppressing ERp57 diminishes osteoclast activity and ameliorates ovariectomy-induced bone loss via the intervention in calcium oscillation and the calmodulin/calcineurin/Nfatc1 pathway.

Journal: Heliyon

Published: April 14, 2024

Inhibition of insulin degrading enzyme suppresses osteoclast hyperactivity via enhancing Nrf2-dependent antioxidant response in glucocorticoid-induced osteonecrosis of the femoral head.

Inhibition of insulin degrading enzyme suppresses osteoclast hyperactivity via enhancing Nrf2-dependent antioxidant response in glucocorticoid-induced osteonecrosis of the femoral head.

Journal: Molecular medicine (Cambridge, Mass.)

Published: March 02, 2024

Crebanine mitigates glucocorticoid-induced osteonecrosis of the femoral head by restoring bone remodelling homeostasis via attenuating oxidative stress.

Crebanine mitigates glucocorticoid-induced osteonecrosis of the femoral head by restoring bone remodelling homeostasis via attenuating oxidative stress.

Journal: Journal of cellular and molecular medicine

Published: February 04, 2024

Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging.

Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging.

Journal: Aging cell

Published: October 17, 2023

Editorial: Molecular mechanisms of osteoporosis.

Editorial: Molecular mechanisms of osteoporosis.

Journal: Frontiers in endocrinology

Published: September 24, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026